Cullinan Oncology
Cullinan Oncology is a biotech company in Cambridge, United States, founded in 2016. It has raised $150.0M across 1 round, most recently a $150.0M Series A in October 2017.
Science That Moves
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- cullinanoncology.com
- Total Funding
- $150.0M
- Last Round
- $150.0M Series AOct 2017
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.
About
Cullinan Therapeutics develops high-impact, differentiated therapies for people living with autoimmune diseases and cancer. The company's clinical-stage pipeline reflects a deliberate approach of advancing only the most promising molecules to address high unmet needs. Cullinan unites scientific expertise, strategic risk-taking, and rigorous decision-making to accelerate immune-modulating therapies so patients spend less time managing their conditions and more time on what matters most.
Summary
It lists 51–200 employees. It has raised $150.0M in total across 1 round, most recently a $150.0M Series A round in Oct 2017. Investors include F2 Ventures.
Funding History
Oct 2017
Investors
Similar Companies
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cullinan-oncology"><img src="https://indexed.vc/api/badge/company/cullinan-oncology" alt="Cullinan Oncology on Indexed.vc" width="260" height="76" /></a>